Healthcare specialist partners with NHS to open £26m cancer care complex in London

HCA Healthcare UK opens the doors to its latest investment in complex cancer care, a £26m specialist complex haematology and oncology unit at HCA Healthcare UK at University College Hospital, London.

The investment is part of HCA UK’s long standing partnership with University College Hospital, providing private patient care at HCA UK at UCH since 2006. It sees the transfer and expansion of inpatient capability into a specially designed state-of-the-art 43-bed unit in the new Grafton Way building.

With the expertise and infrastructure to provide innovative cancer therapies including CAR-T Cell Therapy, TIL Therapy and Haematopoietic Stem Cell Transplants, the development builds on HCA UK’s reputation as the “most comprehensive provider” of cancer care in the independent sector.

The expansion of HCA UK at UCH will enable access to inpatient clinical trials delivered via HCA UK’s research arm, Sarah Canon Research Institute UK.

Claire Smith, CEO of HCA UK NHS Joint Ventures said: “I am delighted to be expanding our inpatient care at HCA UK at UCH, further enhancing our capability and capacity to provide high quality cancer care and leading-edge treatments.

“Every aspect of this development has been designed with patient care and experience at the fore. Features such as the Advanced Cellular Therapy and Hematopoietic Stem Cell Transplant Units are demonstrative of the acute specialist care that we are uniquely positioned to provide at HCA Healthcare UK.

“This is another important milestone in our longstanding partnerships with the NHS, building on the 2021 investment in our theatres at The Christie Private Care and looking ahead to our exciting new development with University Hospitals Birmingham.”

John Reay, President and CEO of HCA Healthcare UK, added: “This £26m investment into HCA UK at UCH is part of our wider commitment to ensuring that across our healthcare system we are providing the complete pathway for cancer patients, from diagnostics through to the most specialist treatment and holistic care.

“This depth and breadth of care, unmatched in the independent sector, attracts patients to us from across the world.”

Our Partners